AIDS News and Research

RSS

Editorials respond to PEPFAR reauthorization

President Bush on Wednesday signed into law legislation (HR 5501) that reauthorizes the President's Emergency Plan for AIDS Relief at $48 billion through 2013. Two newspapers have published editorials in response to the bill.

3 Aug 2008

Abbott Labs agrees to settle lawsuit over antiretroviral Norvir pricing

Abbott Laboratories on Wednesday agreed to pay between $10 million and $27.5 million to settle an antitrust lawsuit filed by HIV/AIDS advocates and other drug companies over an increase in the price of the company's antiretroviral drug Norvir, the AP/International Herald Tribune reports (AP/International Herald Tribune, 7/31).

3 Aug 2008

Certain HIV treatment less effective when used with rifampicin-based anti-tuberculosis therapy

Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely used in developing countries because of lower cost, than when starting efavirenz-based antiretroviral therapy, according to a study in the August 6 issue of JAMA, a theme issue on HIV/AIDS.

3 Aug 2008

Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients on antiviral therapy

Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection.

3 Aug 2008

New figures show need for national HIV/AIDS srategy

The federal Centers for Disease Control and Prevention's (CDC) long anticipated revised estimate of annual new cases of HIV infections was revealed in a paper published in the Aug. 6, 2008 issue of the Journal of the American Medical Association (JAMA). The revised estimated number of new infections suggests that the HIV epidemic here in the United States is more severe than current statistics portray.

3 Aug 2008

Update of treatment guidelines for HIV infection recommended by experts

An evaluation of the latest information on the treatment of the adult human immunodeficiency virus (HIV) has led an international panel of experts to update the guidelines and recommendations for antiretroviral treatment of HIV.

3 Aug 2008

Merck announces significant price cuts on two of its AIDS drugs, Stocrin and Isentress

As more than 20,000 people from around the world gather this weekend for the start of the XVII International AIDS Conference in Mexico City, AIDS Healthcare Foundation (AHF) the US-based NGO which provides HIV/AIDS medical care and/or services to more than 79,000 individuals in 20 countries worldwide-including at four free treatment clinics in Mexico-commended Merck & Company (known as Merck, Sharp & Dohme in Mexico) over price cuts on two of its key AIDS drugs in Mexico which were announced yesterday before Sunday's opening of the AIDS conference.

3 Aug 2008

Cancer patients not given enough information about survival benefits of palliative chemotherapy

Two thirds of cancer patients receive little or no information about the survival benefits of having palliative chemotherapy before making a decision about treatment, according to a study published today on bmj.com.

31 Jul 2008

Inherited form of hearing loss stems from gene mutation

Pat Phalin learned she had hearing loss at 30, when she volunteered to give hearing tests at her local school. The pupils heard sounds she could not hear.

31 Jul 2008

Bacterial vaginosis may increase risk of HIV infection

A common vaginal infection may make women more susceptible to contracting HIV, the virus that causes AIDS, University of North Carolina at Chapel Hill School of Public Health researchers have found.

31 Jul 2008

Rresearchers explain how previously ignored parts of HIV genome play key role in drug resistance

One of the major reasons that treatment for HIV/AIDS often doesn't work as well as it should is resistance to the drugs involved. Now, scientists at McGill University have revealed how mutations hidden in previously ignored parts of the HIV genome play an important role in the development of drug resistance in AIDS patients. Their study will be published Aug. 8 in the Journal of Biological Chemistry.

31 Jul 2008

Countries in Latin America and the Caribbean should improve, expand sexuality education

Countries in Latin America and the Caribbean should improve and expand sexuality education programmes in order to prevent HIV and AIDS and reduce the impact of the epidemic in the region, a group of United Nations agencies said today.

31 Jul 2008

Fight against HIV in mothers and children ramps up

As the world's leaders and AIDS community gather in Mexico for the biennial global conference on HIV and AIDS, UNITAID, UNICEF and the World Health Organization (WHO) today announced an infusion of $50 million aimed at halting mother-to-child transmission of HIV.

31 Jul 2008

Bush signs historic global AIDS bill

AIDS Healthcare Foundation (AHF), hailed President Bush for signing legislation to re-authorize PEPFAR (the President's Emergency Plan for AIDS Relief).

30 Jul 2008

USAID to tackle HIV/AIDS and literacy in Haiti

Increasing literacy and curbing HIV/AIDS is the centerpiece of the U.S. Agency for International Development's (USAID) new three-year effort designed to stabilize parts of Haiti plagued by community unrest.

29 Jul 2008

Report on HIV/AIDS in southern U.S. should 'serve' as 'call to action,' editorial says

A recent report from the Southern AIDS Coalition should "serve as a call to action," a Columbia State editorial says, adding, "While many rightfully call on state and federal officials to provide more funding to pay for drugs, education and other resources to deal with this public health crisis, the epidemic won't be overcome by government funding and influence alone."

29 Jul 2008

HIV vaccine research needs new ideas more funding

New researchers and innovative ideas are needed to further research on developing an HIV/AIDS vaccine, U.S. scientists wrote in Friday's edition of Science magazine, the AP/Google.com reports.

29 Jul 2008

Bush says he will sign PEPFAR reauthorization

President Bush on Saturday during his weekly radio address said he is eager to sign legislation (HR 5501) that would reauthorize the President's Emergency Plan for AIDS Relief through 2013, the AP/Google.com reports (Reichmann, AP/Google.com, 7/26).

29 Jul 2008

HAART increases HIV-positive people's life expectancy by average of 13 years

HIV-positive people in wealthy countries using highly active antiretroviral therapy now live an additional 13 years on average, but a large disparity in life expectancy remains between HIV-positive people on HAART and the general population, according to a study published Friday in the journal Lancet, Reuters reports.

29 Jul 2008

New report examines donor funding for health in low and middle income countries

With the U.S. poised to reauthorize the President's Emergency Plan for AIDS Relief (PEPFAR) and almost triple its financing over the next five years, a new report from the Kaiser Family Foundation looks at trends in health funding provided by donor governments to low- and middle- income countries.

28 Jul 2008